FDA Commissioner Dr. Martin A. Makary said the agency is taking aggressive steps to modernize outdated regulations, expand ...

The FDA is defending a decision to restrict access to a newly-approved low dose COVID vaccine from Moderna that the company ...

Vaccination rates across the country have continued to fall since the height of the pandemic, but the coronavirus never ...

The new mRNA vaccine encodes the receptor-binding domain and the N-terminal domain of the SARS-CoV-2 spike protein ...

Despite uncertainties arising from new FDA policies around COVID-19 vaccines, Moderna has cleared the agency's desk with its ...

Moderna announced this weekend that the Food and Drug Administration approved its lower-dose Covid-19 vaccine for adults 65 ...

The US Food and Drug Administration (FDA) has approved Moderna's new mNEXSPIKE vaccine, designed for the elderly and those ...

The US FDA approved Moderna's next-generation COVID-19 vaccine, mNexspike, for adults 65+ and at-risk individuals aged 12-64.

The Food and Drug administration has approved a new COVID-19 vaccine made by Moderna but with limits on who can use it.

The U.S. Food and Drug Administration has approved Moderna's next-generation COVID-19 vaccine for everyone aged 65 and above, ...

Health Secretary Robert F. Kennedy Jr. recently announced more key changes to the CDC recommendations for COVID-19 ...

In a significant shift this week, Health Secretary Robert F. Kennedy Jr. announced that COVID-19 vaccines will no longer be recommended for healthy children and pregnant individuals. That sparked ...